SpyGlass Pharma, Inc. (SGP): Total Liabilities
$10.17M
As of 2025-12-31
$11.07M
As of 2026-06-30
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.17M | -9.6% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $11.25M | n/a | 2026-03-26, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | 2025-12-31 | $10.17M | -9.6% |
| Sight Sciences, Inc. (SGHT) | 2025-12-31 | $51.36M | -7.2% |
| Orchestra BioMed Holdings, Inc. (OBIO) | 2025-12-31 | $51.48M | +19.1% |
| Fractyl Health, Inc. (GUTS) | 2025-12-31 | $111.94M | +40.5% |
| Utah Medical Products Inc (UTMD) | 2025-12-31 | $3.27M | -35.9% |
| Iradimed Corp (IRMD) | 2025-12-31 | $14.16M | +23.0% |
| Delcath Systems, Inc. (DCTH) | 2025-12-31 | $12.41M | +58.3% |
| Alpha Tau Medical Ltd. (DRTS) | 2025-12-31 | $28.55M | +21.3% |
| NeuroPace Inc (NPCE) | 2025-12-31 | $86.53M | -0.1% |
Compare SGP, SGHT, OBIO, GUTS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗